上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1416Please respect copyright.PENANAGWtKMMkRR3
1416Please respect copyright.PENANAFNH0aUv7JR
上集:https://www.penana.com/article/4711251416Please respect copyright.PENANAO7aJctPzEf
1416Please respect copyright.PENANA5t5YPKdiRa1416Please respect copyright.PENANAiAfLwGoaeD
1416Please respect copyright.PENANAnQi51bNX4R
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1416Please respect copyright.PENANA8yzLzzK5Sx
1416Please respect copyright.PENANAFbya60W0EA
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1416Please respect copyright.PENANA70WTFWI5kg
1416Please respect copyright.PENANAZ5ycgiXBqw
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1416Please respect copyright.PENANACDXCI8grCL
1416Please respect copyright.PENANAZ4IIaYNUOR1416Please respect copyright.PENANAMnBsLaEE3X
1416Please respect copyright.PENANA2bU3TCRsCM
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1416Please respect copyright.PENANA7nZ342XzMg
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1416Please respect copyright.PENANAFBmoWuyfLO
1416Please respect copyright.PENANA7ZHpb3W4cj
忘記甚麼是Neoantigen的話,可重溫上一集。1416Please respect copyright.PENANAUzLbtxkSWi
1416Please respect copyright.PENANAUQV9O8tOKM
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1416Please respect copyright.PENANAcOq8BwNddc
1416Please respect copyright.PENANALBPLsNoBfr
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1416Please respect copyright.PENANA66kFIWi3XC
1416Please respect copyright.PENANAeHaimIGuzY1416Please respect copyright.PENANAt1A593nxRr
1416Please respect copyright.PENANAwGHV8YoxJu
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1416Please respect copyright.PENANAQ1BP90oQvj
1416Please respect copyright.PENANAnXiHTUcynh
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1416Please respect copyright.PENANAkhF1M0AnTf
1416Please respect copyright.PENANAY0tQAZgASC
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1416Please respect copyright.PENANA2qeyUasVV71416Please respect copyright.PENANAXyQeivboRr
1416Please respect copyright.PENANAHdyRZxOEWp
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1416Please respect copyright.PENANA9IYhhSE8X2
1416Please respect copyright.PENANAqzLRWhwsPx
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1416Please respect copyright.PENANAw2Xt2zyFph1416Please respect copyright.PENANAAkcsalnNE8
1416Please respect copyright.PENANAAXYwI7hP3w
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1416Please respect copyright.PENANApxMZ8qKNBT
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1416Please respect copyright.PENANAa6xXulsEjB
1416Please respect copyright.PENANAs9jKCnADIy
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1416Please respect copyright.PENANAk44G9yfe6V
1416Please respect copyright.PENANAxd650i2zmA
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1416Please respect copyright.PENANAvp6h6nN55r
1416Please respect copyright.PENANAscDnc7jYas
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1416Please respect copyright.PENANAWhEYazvIxV
1416Please respect copyright.PENANAhLaqy7bg4o
1416Please respect copyright.PENANASFPNAJFxw6
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1416Please respect copyright.PENANAmEPl1hRiad
1416Please respect copyright.PENANAiJvx4aDO5u
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1416Please respect copyright.PENANAcqm95bnpbA
1416Please respect copyright.PENANAnp9creh9TK
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1416Please respect copyright.PENANAH57oB8nv7W
1416Please respect copyright.PENANAyGHK9gLQIt
Link:1416Please respect copyright.PENANAJdTObvNpf0
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1416Please respect copyright.PENANAaSPaxlv0uG
1416Please respect copyright.PENANAM6ZC5Wt7kS
1416Please respect copyright.PENANAC7U4gjIyfM
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1416Please respect copyright.PENANAbltjAc1jhP
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline 資料
-
toc 目錄
-
share 分享
-
format_color_text 介面設置
-
exposure_plus_1 推薦
-
打賞
-
report_problem 檢舉
-
account_circle 登入
X
科普專欄–薯不揀單
作者:
薯仔聞茱莉

篇 #31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
喜歡 2
閱讀 1412
書籤 150
campaign
催更 0
打賞

按此加載下一章
X
每次催更後,作者都會收到通知!
smartphone100 → 催更
×
寫下你喜歡這個故事的地方
×
對此喜歡的人